Cambridgeshire and Peterborough NHS Foundation Trust launches mental health clinical trials
pharmafile | February 4, 2019 | News story | Sales and Marketing | UK, clinical trials, clozapine, mental health, schizophrenia
The Cambridgeshire and Peterborough NHS Foundation Trust’s Windsor Research Unit is offering patients the chance to participate in clinical trials for new mental health treatments and therapies.
The trust – one of the leading mental health research trusts – are investigating ways through which mental illness can be diagnosed at the earliest stage, as they explore the links between mental and physical illnesses, and improve care and support for patients.
The unit’s mental health team manager, Katherine Cummergen, commented: “We are delighted to start running clinical trials as part of the mental health research portfolio and work with new health partners to test pioneering treatments. The team is dedicated to giving patients and volunteers the best experience and increasing opportunities to take part in research to enhance their care so we can find solutions to improve mental health.”
Anyone who has been diagnosed with schizophrenia can ask their doctor whether the trust’s trial for the antipsychotic medication clozapine may be helpful. The doctor will be able to refer patients to the trial.
Consultant psychiatrist Dr Emilio Fernandez-Egea said: “Research is essential to improve clinical care for our patients. At the Clozapine Clinic I work with many people living with treatment-resistant schizophrenia and want to offer them every chance to try new treatments and therapies. The mental health team at Windsor Research Unit offer fantastic support for researchers and health professionals and this development means we can now integrate clinical trials with care.”
Louis Goss
Related Content
EMA selects TrialAssure anonymisation platform for clinical trial documents
TrialAssure has announced that its ANONYMIZE platform has been selected by the European Medicines Agency …
FDA signals support for development of psychedelic therapies in mental healthmental health
The US Food and Drug Administration (FDA) has announced a series of measures aimed at …
Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month
Stage4You, a campaign funded and developed by Takeda UK and supported by Bowel Cancer UK, …
